Anemia and its relationship to clinical outcome in heart failure

Area of Science:

• Cardiology
• Hematology
• Internal Medicine

Background:

• Anemia is frequently observed in patients with chronic heart failure (CHF).
• The prognostic implications of anemia in CHF patients are not fully understood.
• This study aimed to clarify the relationship between anemia, CHF severity, and clinical outcomes.

Purpose of the Study:

• To investigate the association between anemia and the severity of chronic heart failure.
• To determine the impact of anemia on clinical outcomes, including mortality and hospitalization, in CHF patients.
• To explore the relationship between hemoglobin levels and cardiac structure/function.

Main Methods:

• Analysis of data from 912 patients with CHF in the RENAISSANCE trial.
• Measurement of hemoglobin concentration (Hb) at baseline.
• Cardiac MRI in a subgroup of 69 patients to assess changes in left ventricular mass.

Main Results:

• Anemia (Hb ≤12.0 g/dL) was identified in 12% of the CHF cohort.
• Each 1-g/dL increase in baseline Hb was associated with a 15.8% lower risk of mortality and a 14.2% lower risk of mortality or heart failure hospitalization.
• Lower Hb concentrations correlated with greater CHF severity and increased left ventricular mass; changes in Hb over time mirrored changes in left ventricular mass and mortality risk.

Conclusions:

• Anemia is a prevalent comorbidity in patients with chronic heart failure.
• Anemia is an independent predictor of adverse outcomes, including increased hospitalization and mortality rates in CHF.
• Lower hemoglobin levels are significantly associated with greater CHF disease severity and adverse cardiac remodeling.